Most sold healthcare stocks in Q3 2017
See which Healthcare stocks institutional investors trimmed or exited the most in Q3 2017, measured as net reductions in reported share positions from Q2 2017 into Q3 2017. Notable reductions at the top of this list include ZOETIS INC (ZTS), NOVARTIS AG-SPONSORED ADR (NVS), WALGREENS BOOTS ALLIANCE INC (WBA), ABBOTT LABORATORIES (ABT). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| ZTS | ZOETIS INC | -4,304,813 | -$259.83M | 0 | 0 | 2 | 1 | 3 |
| NVS | NOVARTIS AG-SPONSORED ADR | -4,100,849 | -$208.66M | 1 | 3 | 5 | 0 | 11 |
| WBA | WALGREENS BOOTS ALLIANCE INC | -3,582,543 | -$286.35M | 1 | 3 | 2 | 1 | 9 |
| ABT | ABBOTT LABORATORIES | -3,331,600 | -$139.39M | 0 | 2 | 3 | 2 | 6 |
| DHR | DANAHER CORP | -2,968,361 | -$220.00M | 0 | 2 | 5 | 0 | 10 |
| BKD | BROOKDALE SENIOR LIVING INC | -2,358,324 | -$34.69M | 0 | 0 | 0 | 2 | 0 |
| TDOC | TELADOC HEALTH INC | -2,289,346 | -$82.23M | 1 | 0 | 1 | 0 | 2 |
| JNJ | JOHNSON & JOHNSON | -2,133,375 | -$340.15M | 0 | 5 | 8 | 1 | 18 |
| BAX | BAXTER INTERNATIONAL INC | -1,915,957 | -$14.66M | 0 | 0 | 5 | 0 | 8 |
| ABBV | ABBVIE INC | -1,876,053 | -$102.85M | 0 | 3 | 6 | 1 | 11 |
| BSX | BOSTON SCIENTIFIC CORP | -1,827,212 | -$41.80M | 0 | 1 | 3 | 0 | 4 |
| HALO | HALOZYME THERAPEUTICS INC | -1,728,876 | $8.07M | 0 | 1 | 2 | 0 | 3 |
| UHS | UNIVERSAL HEALTH SERVICES-B | -1,053,508 | -$142.54M | 0 | 1 | 1 | 1 | 2 |
| EXAS | EXACT SCIENCES CORP | -792,211 | -$27.83M | 0 | 0 | 1 | 0 | 1 |
| HCA | HCA HEALTHCARE INC | -788,774 | -$92.39M | 0 | 1 | 1 | 1 | 2 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | -630,253 | -$11.90M | 0 | 0 | 0 | 1 | 0 |
| PHG | KONINKLIJKE PHILIPS NVR- NY | -615,392 | -$20.40M | 0 | 0 | 2 | 0 | 2 |
| AZN | ASTRAZENECA PLC-SPONS ADR | -599,971 | -$32.26M | 0 | 0 | 1 | 1 | 1 |
| SNY | SANOFI-ADR | -597,335 | $96.56M | 0 | 0 | 2 | 0 | 6 |
| BIIB | BIOGEN INC | -593,632 | -$152.26M | 1 | 2 | 2 | 0 | 6 |
| OPK | OPKO HEALTH INC | -538,200 | -$3.24M | 0 | 0 | 1 | 0 | 1 |
| DVA | DAVITA INC | -536,698 | -$241.91M | 0 | 0 | 0 | 2 | 2 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | -473,273 | -$4.83M | 0 | 1 | 0 | 1 | 1 |
| OMI | OWENS & MINOR INC | -466,844 | -$19.94M | 0 | 1 | 1 | 0 | 2 |
| BMY | BRISTOL-MYERS SQUIBB CO | -431,342 | $322.91M | 2 | 1 | 7 | 1 | 11 |
| OSUR | ORASURE TECHNOLOGIES INC | -421,200 | $17.27M | 0 | 0 | 1 | 0 | 1 |
| GRFS | GRIFOLS SA-ADR | -411,434 | $9.99M | 0 | 1 | 1 | 0 | 2 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | -374,164 | -$606.00K | 0 | 0 | 0 | 1 | 0 |
| CNC | CENTENE CORP | -365,833 | -$4.14M | 0 | 1 | 1 | 0 | 2 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | -362,693 | -$73.80M | 0 | 2 | 2 | 1 | 7 |
| PBH | PRESTIGE CONSUMER HEALTHCARE | -353,260 | -$19.23M | 0 | 1 | 1 | 0 | 2 |
| CPRX | CATALYST PHARMACEUTICALS INC | -310,200 | -$995.00K | 0 | 0 | 1 | 0 | 1 |
| MMSI | MERIT MEDICAL SYSTEMS INC | -296,800 | -$10.74M | 0 | 0 | 1 | 0 | 1 |
| THC | TENET HEALTHCARE CORP | -280,042 | -$6.87M | 1 | 0 | 0 | 1 | 1 |
| RDY | DR. REDDY'S LABORATORIES-ADR | -275,400 | -$12.88M | 0 | 0 | 2 | 0 | 2 |
| MRK | MERCK & CO. INC. | -237,321 | -$16.67M | 0 | 8 | 3 | 1 | 14 |
| ANGO | ANGIODYNAMICS INC | -214,210 | -$3.07M | 0 | 0 | 1 | 0 | 1 |
| GLPG | GALAPAGOS NV-SPON ADR | -198,800 | -$8.49M | 0 | 0 | 1 | 0 | 1 |
| ARAY | ACCURAY INC | -184,500 | -$4.03M | 0 | 0 | 1 | 0 | 1 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | -178,000 | -$1.06M | 0 | 0 | 1 | 0 | 1 |
| SENS | SENSEONICS HOLDINGS INC | -176,877 | -$269.00K | 0 | 0 | 1 | 1 | 1 |
| PODD | INSULET CORP | -173,800 | -$8.34M | 0 | 0 | 1 | 0 | 1 |
| CUTR | CUTERA INC | -168,820 | $11.78M | 0 | 0 | 1 | 0 | 1 |
| CRL | CHARLES RIVER LABORATORIES | -167,498 | $4.22M | 0 | 1 | 2 | 0 | 3 |
| HUM | HUMANA INC | -166,907 | -$29.14M | 0 | 1 | 0 | 2 | 1 |
| ICUI | ICU MEDICAL INC | -145,300 | -$19.15M | 0 | 0 | 1 | 0 | 1 |
| RGEN | REPLIGEN CORP | -139,900 | -$6.29M | 0 | 0 | 1 | 0 | 1 |
| GKOS | GLAUKOS CORP | -137,100 | -$9.95M | 0 | 0 | 1 | 0 | 1 |
| TCMD | TACTILE SYSTEMS TECHNOLOGY I | -127,300 | -$3.47M | 0 | 0 | 1 | 0 | 1 |
| ELV | ELEVANCE HEALTH INC | -126,688 | -$8.53M | 0 | 3 | 4 | 0 | 10 |
Frequently asked questions about Most sold healthcare stocks in Q3 2017
What are the most sold Healthcare stocks in Q3 2017?
The most sold healthcare stocks in Q3 2017 are those with the largest decrease in reported share counts across institutional investors compared to Q2 2017, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q3 2017?
Among filers in this sector, net reductions were largest in companies such as ZOETIS INC (ZTS), NOVARTIS AG-SPONSORED ADR (NVS), WALGREENS BOOTS ALLIANCE INC (WBA), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q2 2017).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.